» Articles » PMID: 37041257

Most Patients with COPD Are Unaware of Their Health Threats and Are Not Diagnosed: a National-level Study Using Pulmonary Function Test

Overview
Journal Sci Rep
Specialty Science
Date 2023 Apr 11
PMID 37041257
Authors
Affiliations
Soon will be listed here.
Abstract

This study aimed to investigate national-level prevalence of COPD, proportion of patients diagnosed with and without COPD. We performed pulmonary function test (PFT) in 24,454 adults aged > 40 years for 8 years (2010-2017). The annual COPD prevalence increased from 13.1% in 2010 to 14.6% in 2012, followed by 13.3% in 2017. However, patients diagnosed with COPD ranged between 0.5 and 1.0% in the last 8 years, which means that only 5% of all COPD patients were diagnosed with COPD by doctors. We defined potential high-risk individuals as those with a FEV/FVC ratio of < 0.70, who have not been diagnosed with COPD and other respiratory diseases tuberculosis, asthma, lung cancer. The proportion of this group was 80.8% in 2010 and 78.1% in 2017. The older age group, women, low-educated group, and current smokers who have been smoking for a long time are more likely to be in the high-risk group having a higher possibility to develop COPD but are not diagnosed with COPD appropriately. Although COPD prevalence was high in the ever, current, and heavy smokers, only the diagnosis rate of COPD in ever smokers was 2.38 times higher than never smokers, indicating that a system is needed to screen and intervention for these groups.

Citing Articles

Clinical characteristics of obese, fixed airway obstruction, exacerbation-prone phenotype and comorbidities among severe asthma patients: a single-center study.

Zhu G, Mo Y, Ye L, Cai H, Zeng Y, Zhu M BMC Pulm Med. 2024; 24(1):76.

PMID: 38336682 PMC: 10854120. DOI: 10.1186/s12890-023-02835-4.

References
1.
Hurd S, Pauwels R . Global Initiative for Chronic Obstructive Lung Diseases (GOLD). Pulm Pharmacol Ther. 2002; 15(4):353-5. DOI: 10.1006/pupt.2002.0381. View

2.
Buist A, McBurnie M, Vollmer W, Gillespie S, Burney P, Mannino D . International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007; 370(9589):741-50. DOI: 10.1016/S0140-6736(07)61377-4. View

3.
Kaplan A, Thomas M . Screening for COPD: the gap between logic and evidence. Eur Respir Rev. 2017; 26(143). PMC: 9489098. DOI: 10.1183/16000617.0113-2016. View

4.
Gershon A, Mecredy G, Guan J, Victor J, Goldstein R, To T . Quantifying comorbidity in individuals with COPD: a population study. Eur Respir J. 2014; 45(1):51-9. DOI: 10.1183/09031936.00061414. View

5.
Kaluza J, Harris H, Linden A, Wolk A . Alcohol Consumption and Risk of Chronic Obstructive Pulmonary Disease: A Prospective Cohort Study of Men. Am J Epidemiol. 2019; 188(5):907-916. DOI: 10.1093/aje/kwz020. View